SCHEMBL10551867

SCHEMBL10551867

O=C1CCC(c2cccnc2-n2cncn2)=NN1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ SMN1; SMN2 Q16637 1/20 0.40
▸ PDE3B Q13370 9/20 0.40
▸ PDE3A Q14432 9/20 0.40
▸ LMNA P02545 2/20 0.40
▸ PDE4B Q07343 2/20 0.40
▸ CYP1A2 P05177 1/20 0.40
▸ CYP3A4 P08684 1/20 0.40
▸ CYP2D6 P10635 1/20 0.40
▸ CYP2C9 P11712 1/20 0.40
▸ TSHR P16473 1/20 0.40
▸ PDE4A P27815 1/20 0.40
▸ MAPK1 P28482 1/20 0.40
▸ CYP2C19 P33261 1/20 0.40
▸ PDE4C Q08493 1/20 0.40
▸ PDE4D Q08499 1/20 0.40
▸ PDE2A O00408 2/20 0.37
▸ KCNH2 Q12809 1/20 0.37
▸ PTGS1 P23219 1/20 0.36
▸ PTGS2 P35354 1/20 0.36
▸ ALOX5AP P20292 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10552304 0.80 SMN1; SMN2 (0.44) SMN1; SMN2PDE3BPDE3ALMNAPDE4B
SCHEMBL7277988 0.73 PDE3B (0.60) SMN1; SMN2PDE3BPDE3ALMNAPDE4B
SCHEMBL11254453 0.72 SMN1; SMN2 (0.50) SMN1; SMN2PDE3BPDE3ALMNAPDE4B
SCHEMBL2788049 0.70 CYP2A6 (0.44) SMN1; SMN2LMNAALOX5APCYP2A6GRM4
SCHEMBL10911962 0.68 SMN1; SMN2 (0.53) SMN1; SMN2PDE3BPDE3ALMNAPDE4B
SCHEMBL7152208 0.68 CYP2A6 (0.53) SMN1; SMN2LMNACYP1A2CYP3A4CYP2D6
SCHEMBL17103799 0.66 SMN1; SMN2 (0.56) SMN1; SMN2PDE3BPDE3ALMNAPDE4B
SCHEMBL29935775 0.65 CYP2A6 (0.47) SMN1; SMN2LMNACYP1A2CYP3A4CYP2D6
SCHEMBL9826144 0.65 CYP2A6 (0.47) SMN1; SMN2LMNACYP1A2CYP2D6CYP2C9
SCHEMBL8237489 0.65 CYP2A6 (0.44) SMN1; SMN2CYP1A2CYP2D6CYP2C9CYP2C19

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-4847251-A CARDIOVASCULAR DISORDERS BOEHRINGER MANNHEIM GMBH (DE) 1989-07-11 — — US disclosed
EP-0255704-A2 Pyridazinone derivatives, process for their preparation and their use as medicines Roche Diagnostics GmbH (DE) 1988-02-10 — — EP disclosed
Send feedback